ArticleFrontiers in oncology2021

A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment.

Jianyao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.